RNA-guided gene activation by CRISPR-Cas9–based transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, D. Dewran Koçak et al.|Nature Methods|2013Cited by 1.3k
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophyChristopher E. Nelson, Charles A. Gersbach, Chady H. Hakim et al.|Science|2015Cited by 1.1k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G. Ousterout, Charles A. Gersbach, Ami M. Kabadi et al.|Nature Communications|2015Cited by 456
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M. Kabadi, Charles A. Gersbach, David G. Ousterout et al.|Nucleic Acids Research|2014Cited by 388
Synergistic and tunable human gene activation by combinations of synthetic transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, David G. Ousterout et al.|Nature Methods|2013Cited by 241